Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developments in microarray technologies.

David N Howbrook1, Anne M van der Valk, Meg C O'Shaughnessy

  • 1School of Pharmacy and Biomolecular Sciences, University of Brighton, Moulsecoomb, Brighton BN2 4GJ, UK.

Drug Discovery Today
|July 18, 2003
PubMed
Summary

Microarray technology is advancing drug discovery by enabling high-throughput screening of proteins and small molecules. This progression from genomics to proteomics and beyond enhances efficiency and reduces sample volume for complex biological assessments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Connexin 32 constrains a mesenchymal-like switch in differentiated urothelium and luminal cancers.

Life science alliance·2026
Same author

A contact lens-embedded betaine ester polymer for pH-responsive release of an osmoprotectant to the corneal surface.

International journal of pharmaceutics·2026
Same author

Virus-induced APOBEC3 transmutagenesis in bladder cancer initiation.

Science advances·2025
Same author

Single-use materials and poorly recycled waste in intensive care: An argument for improving sustainability.

Nursing in critical care·2025
Same author

The Urothelial Transcriptomic Response to Interferon Gamma: Implications for Bladder Cancer Prognosis and Immunotherapy.

Cancers·2022
Same author

LPCAT4 Knockdown Alters Barrier Integrity and Cellular Bioenergetics in Human Urothelium.

International journal of molecular sciences·2022

Area of Science:

  • Biotechnology
  • Drug Discovery
  • Genomics and Proteomics

Background:

  • High-throughput drug discovery is expanding beyond genomics and transcriptomics.
  • Current research focuses on complex biological assessments of the proteome, glycome, and metabolome.
  • Microarrays are a key technology for analyzing gene expression and screening molecular libraries.

Purpose of the Study:

  • To highlight the evolving role of microarrays in drug discovery.
  • To discuss the application of microarrays in assessing complex biological systems.
  • To explore the potential of microarray technology in advancing proteomic, glycomic, and tissue analysis.

Main Methods:

  • Utilizing microarrays for gene expression analysis (cDNA or RNA).
  • Employing microarrays for screening libraries of proteins and small molecules.

Related Experiment Videos

  • Developing advanced microarray formats for proteomic, glycomic, and tissue applications.

    • Main Results:

    • Microarrays enable extraction of more information from smaller sample volumes.
    • The technology facilitates the incorporation of low-cost, high-throughput assays.
    • Microarrays are being adapted for more challenging biological assessments.

    Conclusions:

    • Microarray technology is crucial for efficient high-throughput drug discovery.
    • The continued development of microarrays supports the assessment of complex biological data.
    • Future applications in proteomic, glycomic, and tissue arrays promise to further enhance drug discovery.